Table 2.
% | Nil/scant | Low | Moderate | Heavy |
---|---|---|---|---|
Bacterial burden | ||||
Ceasing | 51·4 | 18·9 | 24·3 | 5·4 |
Antimicrobial | ||||
Treatment swab (n = 37) | ||||
6th‐week swab (n = 107) | 26·2 | 29·9 | 15·0 | 29·0 |
12th‐week swab (n = 57) | 31·6 | 26·3 | 24·6 | 17·5 |
Leukocytes growth | ||||
Ceasing | 84·7 | 6·5 | 6·5 | 2·2 |
Antimicrobial | ||||
Treatment swab (n = 46) | ||||
6th‐week swab (n = 115) | 73·1 | 17·4 | 8·7 | 0·9 |
12th‐week swab (n = 61) | 70·5 | 18·0 | 11·5 | – |